Nuvectis launches Phase 1a dose escalation clinical trial of new cancer drug
The Medical News,
Clinical trials have begun for a drug candidate for hard-to-treat cancers, discovered at the University of Edinburgh and…
Clinical trials have begun for a drug candidate for hard-to-treat cancers, discovered at the University of Edinburgh and…
Scientists in Edinburgh have signed a multi-million-dollar deal to turn their research into new medicines for hard-to-treat…
Scientists in Edinburgh have signed a multi-million-dollar deal to turn their research into new medicines for hard-to-treat…
Scientists in Edinburgh have signed a multi-million-dollar deal to turn their research into new medicines for hard-to-treat…